Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC

NCT00767377 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
163
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fudan University